Wang M - Search Results

1

An Integrated Lipidomics and Phenotype Study Reveals Protective Effect and Biochemical Mechanism of Traditionally Used Alisma orientale Juzepzuk in Chronic Kidney Disease.

Dou F, Miao H, Wang JW, Chen L, Wang M, Chen H, Wen AD, Zhao YY. Dou F, et al. Among authors: wang jw, wang m. Front Pharmacol. 2018 Feb 8;9:53. doi: 10.3389/fphar.2018.00053. eCollection 2018. Front Pharmacol. 2018. PMID: 29472858 Free PMC article.

2

Hemispheric lateralization for early auditory processing of lexical tones: dependence on pitch level and pitch contour.

Wang XD, Wang M, Chen L. Wang XD, et al. Among authors: wang m. Neuropsychologia. 2013 Sep;51(11):2238-44. doi: 10.1016/j.neuropsychologia.2013.07.015. Epub 2013 Aug 1. Neuropsychologia. 2013. PMID: 23911775

3

Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression.

Chen H, Cao G, Chen DQ, Wang M, Vaziri ND, Zhang ZH, Mao JR, Bai X, Zhao YY. Chen H, et al. Among authors: wang m. Redox Biol. 2016 Dec;10:168-178. doi: 10.1016/j.redox.2016.09.014. Epub 2016 Sep 28. Redox Biol. 2016. PMID: 27750081 Free PMC article.

4

The link between phenotype and fatty acid metabolism in advanced chronic kidney disease.

Chen DQ, Chen H, Chen L, Vaziri ND, Wang M, Li XR, Zhao YY. Chen DQ, et al. Among authors: wang m. Nephrol Dial Transplant. 2017 Jul 1;32(7):1154-1166. doi: 10.1093/ndt/gfw415. Nephrol Dial Transplant. 2017. PMID: 28339984 Free article.

5

Role of RAS/Wnt/β-catenin axis activation in the pathogenesis of podocyte injury and tubulo-interstitial nephropathy.

Chen L, Chen DQ, Wang M, Liu D, Chen H, Dou F, Vaziri ND, Zhao YY. Chen L, et al. Among authors: wang m. Chem Biol Interact. 2017 Aug 1;273:56-72. doi: 10.1016/j.cbi.2017.05.025. Epub 2017 Jun 2. Chem Biol Interact. 2017. PMID: 28578904 Free article.

6

Metabolomics highlights pharmacological bioactivity and biochemical mechanism of traditional Chinese medicine.

Wang M, Chen L, Liu D, Chen H, Tang DD, Zhao YY. Wang M, et al. Chem Biol Interact. 2017 Aug 1;273:133-141. doi: 10.1016/j.cbi.2017.06.011. Epub 2017 Jun 13. Chem Biol Interact. 2017. PMID: 28619388 Review.

7

Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-β/Smad signaling pathway.

Wang M, Chen DQ, Wang MC, Chen H, Chen L, Liu D, Zhao H, Zhao YY. Wang M, et al. Among authors: wang mc. Phytomedicine. 2017 Dec 1;36:243-253. doi: 10.1016/j.phymed.2017.10.008. Epub 2017 Oct 12. Phytomedicine. 2017. PMID: 29157821

8

Novel RAS Inhibitors Poricoic Acid ZG and Poricoic Acid ZH Attenuate Renal Fibrosis via a Wnt/β-Catenin Pathway and Targeted Phosphorylation of smad3 Signaling.

Wang M, Chen DQ, Chen L, Liu D, Zhao H, Zhang ZH, Vaziri ND, Guo Y, Zhao YY, Cao G. Wang M, et al. J Agric Food Chem. 2018 Feb 28;66(8):1828-1842. doi: 10.1021/acs.jafc.8b00099. Epub 2018 Feb 14. J Agric Food Chem. 2018. PMID: 29383936 Free article.

9

Proteomics for Biomarker Identification and Clinical Application in Kidney Disease.

Chen L, Su W, Chen H, Chen DQ, Wang M, Guo Y, Zhao YY. Chen L, et al. Among authors: wang m. Adv Clin Chem. 2018;85:91-113. doi: 10.1016/bs.acc.2018.02.005. Epub 2018 Mar 6. Adv Clin Chem. 2018. PMID: 29655463 Review.

10

Novel inhibitors of the cellular renin-angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt/β-catenin pathway against renal fibrosis.

Wang M, Chen DQ, Chen L, Cao G, Zhao H, Liu D, Vaziri ND, Guo Y, Zhao YY. Wang M, et al. Br J Pharmacol. 2018 Jul;175(13):2689-2708. doi: 10.1111/bph.14333. Epub 2018 May 22. Br J Pharmacol. 2018. PMID: 29679507 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68,524 results

Search Page

Filters